Cita APA

Zeng, J., Yin, J., Song, X., Jin, Y., Li, Y., & Pan, L. (2016). Reduction of CA125 Levels During Neoadjuvant Chemotherapy Can Predict Cytoreduction to No Visible Residual Disease in Patients with Advanced Epithelial Ovarian Cancer, Primary Carcinoma of Fallopian tube and Peritoneal Carcinoma. J Cancer.

Chicago Style Citation

Zeng, Jing, Jie Yin, Xiao Song, Ying Jin, Yan Li, i Lingya Pan. "Reduction of CA125 Levels During Neoadjuvant Chemotherapy Can Predict Cytoreduction to No Visible Residual Disease in Patients With Advanced Epithelial Ovarian Cancer, Primary Carcinoma of Fallopian Tube and Peritoneal Carcinoma." J Cancer 2016.

Cita MLA

Zeng, Jing, et al. "Reduction of CA125 Levels During Neoadjuvant Chemotherapy Can Predict Cytoreduction to No Visible Residual Disease in Patients With Advanced Epithelial Ovarian Cancer, Primary Carcinoma of Fallopian Tube and Peritoneal Carcinoma." J Cancer 2016.